FILTER

FILTERED INTERVIEW RESULTS

Mining

United States

Jason Latkowcer

PRESIDENT, CEO AND DIRECTOR, PAN AMERICAN ENERGY CORP.

"Proving commercially viable lithium mineralization has the potential for tremendous value generation for investors."

United States

Pharma & Life Sciences

Tom Sellig

CEO, ADARE PHARMA SOLUTIONS

"For every challenge, we have a set of tools we can leverage to create optimized solutions beyond taste masking."

United States

Pharma & Life Sciences

Louis Kassa

PRESIDENT AND CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)

"I hope to continue seeing companies coming from across the country contributing to the significant growth of the greater Philadelphia area in life sciences."

Mining

United States

Raphael Carmona

VICE PRESIDENT, SALES AREA NORTH AMERICA - SANDVIK ROCK PROCESSING SOLUTIONS, SANDVIK

"When it comes to technology, we want a single software platform gathering all data from the crushers, so the customer to be able to monitor all of them in a centralized space."

Mining

United States

Ron White

PRESIDENT, 3D-P

"Applications for productivity, efficiency, safety, and sustainability increase all require a strong network."

United States

Pharma & Life Sciences

Denis Dufrane

CO-FOUNDER AND CEO, NOVADIP

"I believe 2023 and 2024 will be key for Novadip. We have already closed two trials in the autologous program. We are now in Phase 1/2 trials for CPT in young patients, both in the US and in Europe."

United States

Pharma & Life Sciences

Jeff Butler

PRESIDENT, AMPAC FINE CHEMICALS

"AFC’s core technology differentiators include energetic chemistry, high potency manufacturing, and extensive chromatographic separation capabilities."

United States

Pharma & Life Sciences

Tyrone Brewer

PRESIDENT, US ONCOLOGY, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON

"I am excited about Janssen’s aspirational vision to eliminate cancer. With targeted therapies and immunotherapies, cancer treatment can be more effective and less toxic, enabling individuals to manage their disease while also maintaining their quality of life."

United States

Pharma & Life Sciences

Joe Panetta

PRESIDENT AND CEO, BIOCOM CALIFORNIA

"The lifecycle of new product introduction into the market will now be shorter, as companies have fewer years to recover revenue as a result of the IRA."

Mining

United States

Alan Driscoll

VP, DIRECTOR OF MINING SERVICES, FORSGREN ASSOCIATES

"The changing regulatory environment, pressure to streamline the permitting process, and significant investment coming into the state are all driving real-time planning, creative strategies, and good organization."